Checkpoint Trend

50
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE396H01019
  • NSEID:
  • BSEID: 531099
INR
112.20
-2.25 (-1.97%)
BSENSE

Feb 03

BSE+NSE Vol: 2.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -55.75% vs -2.60% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 89.90% vs 136.18% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 150.00% vs 203.03% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -15.89% vs 138.45% in Mar 2024

Compare Profit and Loss Results of Checkpoint Trend
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
0.00
285.00
-285.00
-100.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
0.00
285.00
-285.00
-100.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-2.00
2.00
100.00%
Raw Materials Consumed
0.00
269.00
-269.00
-100.00%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
0.00
2.00
-2.00
-100.00%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
0.00
275.00
-275.00
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
10.00
-10.00
-100.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
11.00
-11.00
-100.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
10.00
-10.00
-100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
9.00
-9.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
9.00
-9.00
-100.00%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
0.00
7.00
-7.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-4.00
61.00
-65.00
-106.56%
Profit Available for appropriations
-4.00
69.00
-73.00
-105.80%
Appropriations
-4.00
69.00
-73.00
-105.80%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
0.05
23.02
-22.97
-99.78%
Profit And Loss - Net Sales
Net Sales 0.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -55.75% vs -2.60% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 89.90% vs 136.18% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 150.00% vs 203.03% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -15.89% vs 138.45% in Mar 2024